PPLPHARMA

Piramal Pharma Share PricePiramal Pharma

₹69.85
1.4 (2.05%)
As on 24 March, 2023 | 01:53 BSE: 543635 NSE: PPLPHARMA

Piramal Pharma Performance

Day Range

  • Low
  • High

52 Week Range

  • Low
  • High
  • Open Price
  • Previous Close
  • Volume

Start SIP in Piramal Pharma

Start SIP

Piramal Pharma Share Price

  • Over 1 Month -15.89%
  • Over 3 Month -39%

Piramal Pharma Key Statistics

P/E Ratio
PEG Ratio
Market Cap Cr 8,335
Price to Book Ratio
EPS 2.9
Dividend 0
Relative Strength Index 27.6
Money Flow Index 30.46
MACD Signal -7.12
Average True Range 3.28

Piramal Pharma Investment Rating

  • Master Rating:
  • Piramal Pharma has an operating revenue of Rs. 8,012.92 Cr. on a trailing 12-month basis. An annual revenue growth of 6% is not great, Pre-tax margin of 14% is healthy, ROE of 6% is fair but needs improvement. The company has a reasonable debt to equity of 9%, which signals a healthy balance sheet. The stock from a technical standpoint is trading below to its key moving averages. It needs to take out these levels and stay above it to make any meaningful move. From an O'Neil Methodology perspective, the stock has an EPS Rank of 4 which is a POOR score indicating inconsistency in earnings, a RS Rating of 1 which is POOR indicating the underperformance as compared to other stocks, Buyer Demand at D- which indicates heavy supply, Group Rank of 93 indicates it belongs to a poor industry group of Medical-Diversified and a Master Score of E is the worst. Overall, the stock has poor technical strength and poor fundamentals, there are superior stocks in the current market environment.

EPS Strength

Price Strength

Buyer Demand

Group Rank

Piramal Pharma Financials
IndicatorDec 2022Sep 2022Jun 2022
Oper Rev Qtr Cr 813829746
Operating Expenses Qtr Cr 786782813
Operating Profit Qtr Cr 2747-66
Depreciation Qtr Cr 474745
Interest Qtr Cr 332920
Tax Qtr Cr 335-7
Net Profit Qtr Cr -247-17

Piramal Pharma Technicals

EMA & SMA

Current Price
₹69.85
1.4 (2.05%)
  • Bullish Moving Average
  • ___
  • 3
  • Bearish Moving Average
  • ___
  • 10
  • 20 Day
  • 74.58
  • 50 Day
  • 89.1
  • 100 Day
  • 112.29
  • 200 Day
  • 20 Day
  • 74.02
  • 50 Day
  • 90.4
  • 100 Day
  • 111.71
  • 200 Day

Piramal Pharma Resistance and Support

PIVOT
₹69.04
Resistance
First Resistance 69.87
Second Resistance 71.29
Third Resistance 72.12
RSI 27.6
MFI 30.46
MACD Single Line -7.12
MACD -6.49
Support
First Resistance 67.62
Second Resistance 66.79
Third Resistance 65.37

Piramal Pharma Delivery and Volume

Period NSE + BSE Volume Avg NSE + BSE Delivery Volume Avg NSE + BSE Delivery Volume %
Day 5,084,542 265,667,320 52.25
Week 4,761,370 246,734,214 51.82
1 Month 3,825,278 217,122,758 56.76
6 Month 4,109,055 265,157,308 64.53

Piramal Pharma Result Highlights

Piramal Pharma Synopsis

NSE-Medical-Diversified

Piramal Pharma belongs to the Industry of Pharmaceuticals. Company’s Total Operating Revenue is Rs. 3094.95 Cr. and Equity Capital is Rs. 1185.91 Cr. for the Year ended 31/03/2022. Piramal Pharma Ltd. is a Public Limited Listed company incorporated on 04/03/2020 and has its registered office in the State of Maharashtra, India. Company’s Corporate Identification Number(CIN) is U24297MH2020PLC338592 and registration number is 338592.
Market Cap 8,335
Sales 5,484
Shares in Float 77.57
No of funds 242
Yield
Book Value 1.63
U/D Vol ratio 0.3
LTDebt / Equity 9
Alpha -0.73
Beta 1.25

Piramal Pharma

Owner NameDec-22Oct-22
Promoters 34.79%34.79%
Mutual Funds 0.51%0.54%
Insurance Companies 4.17%4.22%
Foreign Portfolio Investors 21.29%27.36%
Financial Institutions/ Banks
Individual Investors 11.8%7.42%
Others 27.44%25.67%

Piramal Pharma Management

Name Designation
Mrs. Nandini Piramal Chairperson
Mr. Peter DeYoung Executive Director
Mr. Vivek Valsaraj Executive Director & CFO
Mr. Neeraj Bharadwaj Non Executive Director
Mr. S Ramadorai Independent Director
Mr. Jairaj Purandare Independent Director
Mr. Peter Stevenson Independent Director
Mr. Sridhar Gorthi Independent Director
Mr. Nathalie Leitch Non Executive Director
Ms. Vibha Paul Rishi Independent Director

Piramal Pharma Forecast

Price Estimates

2,000(9.8%)
1,758(-3.5%)
1,590(-12.7%)

Other Analyst Rating

Piramal Pharma MF Shareholding

Name Amount(cr)
Quant Active Fund Growth 3532
Quant Tax Plan Growth 2779
Quant Mid Cap Fund Growth 1551
Tata Banking & Financial Services Fund Regular Growth 1272
Quant Large and Mid Cap Fund Growth 653

Piramal Pharma FAQs

What is Share Price of Piramal Pharma ?

Piramal Pharma share price is ₹69 As on 24 March, 2023 | 01:39

What is the Market Cap of Piramal Pharma ?

The Market Cap of Piramal Pharma is ₹8335.3 Cr As on 24 March, 2023 | 01:39

What is the P/E ratio of Piramal Pharma ?

The P/E ratio of Piramal Pharma is As on 24 March, 2023 | 01:39

What is the PB ratio of Piramal Pharma ?

The PB ratio of Piramal Pharma is As on 24 March, 2023 | 01:39

Q2FY23

Start Investing Now!

Open Free Demat Account in 5 mins

Enter Valid Mobile Number